Cancer News and Research

Latest Cancer News and Research

Role of ethnicity in nonalcoholic fatty liver disease

The first study to examine nonalcoholic fatty liver disease (NAFLD) among different ethnic and racial groups in the United States finds that Hispanics may be at a higher risk of developing the condition. The study is published in Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD). Published by John Wiley & Sons, Inc., Hepatology is available online via Wiley InterScience.

19 Jan 2005

Small is beautiful in the medical world

Small is beautiful in the medical world. And being able to give European industry the edge in a nearly €200 billion worldwide biomedical market is what drives a consortium of EU-backed partners to make and market smaller, cheaper and better biomedical devices and innovative new applications.

19 Jan 2005

FDA knocks back anticancer drug Marqibo

Inex Pharmaceuticals announced today that United States Food and Drug Administration (FDA) provided an action letter detailing that the anticancer drug Marqibo (vincristine sulfate liposomes injection) is "not approvable" under the FDA's accelerated approval regulations based on the phase 2 clinical trial data submitted.

19 Jan 2005

Psychiatric disorders detected using blood test

ChondroGene Limited reported today that a paper entitled "Assessing the Validity of Blood- Based Gene Expression Profiles for the Classification of Schizophrenia and Bipolar Disorder: A preliminary Report" is available online on the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics' website.

19 Jan 2005

Racial disparities in access to surgical evaluation

African Americans with esophageal cancer are half as likely as whites to be seen by a surgeon and to receive life-prolonging surgery, a new study shows.

19 Jan 2005

Adding radiation therapy to chemotherapy improves survival in patients with high-risk breast cancer

For patients with high-risk breast cancer treated with radical mastectomy and adjuvant chemotherapy, the addition of radiation therapy leads to better survival outcomes with few long-term toxic effects, according to a 20-year follow-up of a randomized trial, which appears in the January 19 issue of the Journal of the National Cancer Institute.

19 Jan 2005

The European mammography systems market

With breast cancer being identified as one of the leading causes of death among European women, several governments have begun to launch extensive screening and awareness programmes across the region. However, some countries have still not implemented the planned programmes due to budgetary or socio-economic constraints.

19 Jan 2005

Screening tests find colorectal cancer in its earliest stages when it can be treated more successfully

Colorectal cancer (CRC) is second only to lung cancer as the leading cause of cancer-related death in the United States. In 2004, it’s estimated that CRC caused nearly 57,000 deaths.

18 Jan 2005

Broadening treatment to battle recurrence of endometrial cancer

Mayo Clinic researchers studying endometrial cancer have found that patients at risk for relapse based on identified risk factors had a 46 percent probability of experiencing recurrence within five years despite treatment with state-of-the-art therapy.

18 Jan 2005

Elsevier to launch journal devoted to nanomedicine

Elsevier has announced plans to launch a peer-reviewed journal devoted to nanomedicine - the emerging science of using molecular machines to treat human disease. Nanomedicine: Nanotechnology, Biology, and Medicine, the official publication of the American Academy of Nanomedicine, will be published quarterly, with the first issue to appear in March 2005.

18 Jan 2005

New insight into how tumor cells can become resistant to anti-cancer therapy

The scientists observed that a protein called P-glycoprotein (P-gp), which causes resistance to chemotherapy in many tumor types, is able to physically “jump” or transfer between tumor cells and retain its functional properties, protecting otherwise sensitive cells from the effects of anti-cancer treatment in vivo and in vitro.

18 Jan 2005

Further evidence for the role of cyclooxygenases (COX) in heart-disease risk

In two articles, published in Circulation, researchers from the University of Pennsylvania School of Medicine provide further evidence for the role of cyclooxygenases (COX) in heart-disease risk.

17 Jan 2005

Research leads to new antiangiogenic drugs

Scientists have uncovered critical information that may lead to an urgently needed method for effective monitoring of antiangiogenic cancer therapies.

17 Jan 2005

Study provides insight into strategies for telomere-based molecular cancer therapeutics

A new study published in the January issue of Cancer Cell provides exciting new information about how to boost the effectiveness of a promising cancer treatment that targets telomeres in an attempt to interfere with the ability of a cancer cell to continuously divide.

17 Jan 2005

Jump starting T cells in skin cancer

Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins.

17 Jan 2005

Few smokers make use of the help that is available

Antidepressant medicines, nicotine replacement products, and counseling can all help a smoker stick with that New Year's resolution to kick the habit. But a study by American Cancer Society researchers finds that few smokers make use of the help that is available.

17 Jan 2005